1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2024Nationwide real-world practice pattern and clinical data of palbociclib in patients with HR(+), HER2(-) metastatic breast cancer (KCSG BR21–15)Journal of Clinical Oncology
2024Primary prophylaxis with pegylated-granulocyte colony-stimulating factor for patients with unresectable pancreatic cancer treated with modified-FOLFIRINOX: A randomized phase II trialJournal of Clinical Oncology
2024A first-in-human trial of selective CDK7 inhibitor Q901, in patients with advanced solid tumors: Interim results of a phase I study (QRNT-009).Journal of Clinical Oncology
202410-Year Risk Prediction of Higher-Grade AV Block in Patients with First-Degree AV Block AMIA ... Annual Symposium proceedings. AMIA Symposium
2024Zanidatamab in previously-treated HER2-positive (HER2+) biliary tract cancer (BTC): Overall survival (OS) and longer follow-up from the phase 2b HERIZON-BTC-01 study.Journal of Clinical Oncology
2025Dual-energy X-ray absorptiometry based biofidelic finite element models for simulating falls to the hip: Impact of trochanteric soft tissue thickness on fracture riskClinical Biomechanics
2025Prevalence and Outcomes of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease: A Multinational Study across Asia Clinical Gastroenterology and Hepatology
2025Clinical Utility of an AI-Based Retinal Imaging Model for Cardiovascular Risk Prediction in Hypertensive RetinopathyCanadian Journal of Ophthalmology
2025Advancements and Challenges in Acute Heart Failure Management in Korea: Initial Report and Insights from the Korean Heart Failure III RegistryJournal of Cardiac Failure
2025Preference for On-Demand Fexuprazan Therapy in Gastroesophageal Reflux Disease: A Prospective Cohort Study Journal of Personalized Medicine
2025Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial Nature Cancer
2025Phase III of oral paclitaxel (DHP107) vs intravenous paclitaxel in HER2-negative recurrent or metastatic breast cancer (mBC): Primary analysis of a multinational optimal trial (NCT03315364).Journal of Clinical Oncology
2025Establishing a National Quality of Care Framework for Heart Failure in Korea: Keep Standards for Heart Failure (KSHF) Initiative International Journal of Heart Failure
2025Impact of Diabetes on Long-Term Outcomes of Percutaneous Coronary Intervention for Coronary Bifurcation Lesions Catheterization and Cardiovascular Interventions
2024Sex/Gender Differences in Respiratory DiseasesSex/Gender-Specific Medicine in Clinical Areas
2024Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide Journal of Liver Cancer(대한간암학회지)
2024Phase II study of GEN-001 in combination with avelumab in patients with PD-L1–positive locally advanced, or metastatic gastric cancer (GC) or gastroesophageal junction cancer (GEJC) who have progressed after second-line (2L) and beyond (GEN001-201 study).Journal of Clinical Oncology
2024First-line pembrolizumab (pembro) plus chemotherapy (chemo) for advanced esophageal cancer: 5-year outcomes from the phase 3 KEYNOTE-590 study.Journal of Clinical Oncology
2024MORPHEUS-EC: A phase Ib/II open-label, randomized study of first-line tiragolumab (tira) + atezolizumab (atezo) + chemotherapy (CT) in patients (pts) with esophageal cancer (EC).Journal of Clinical Oncology
2024Neoadjuvant S-1 plus cisplatin-based chemoradiotherapy compared with surgery alone for locally advanced gastric cancer: Randomized, phase II trial.Journal of Clinical Oncology

Recent Submissions

Browse

Links